22
Participants
Start Date
July 1, 2023
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
Hyperthermia Trial
"Individuals will be exposed to a controlled hyperthermia trial during Visit 2 of the protocol."
Control Trial
"Individuals will be exposed to a control trial (no hyperthermia) during Visit 1 of the protocol."
Texas Health Presbyterian Hospital Dallas, Dallas
University of Texas Southwestern Medical Center
OTHER